InsidersTradesSigma
Follow the 药石科技 share price and the full management transaction log of the company, a listed equity based in China. Shares trade on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 药石科技 has logged 4 insider filings. Market capitalisation: €8.9bn. The latest transaction was filed on 23 August 2024 (Purchase). Among the most active insiders: 刘郝敏. All data is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
药石科技 is a company focused on the health and pharmaceutical sector, providing innovative solutions for disease treatment. It is listed on the XSHE market.